Effect of sesamin supplementation in rheumatoid arthritis wome
Phase 2
- Conditions
- Rheumatoid arthritis.Seropositive rheumatoid arthritis
- Registration Number
- IRCT2013111715424N1
- Lead Sponsor
- Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 44
Inclusion Criteria
Willing to participate in study; Clinical diagnosis of rheumatoid arthritis (meeting the American college of rheumatology 1987 criteria); No smoking or addiction; No drug type and dose fluctuation since 1 month prior to the study and during intervention period ; Not having severe cardiovascular; hepatic; kidney; gastrointestinal; thyroid; parathyroid diseases; diabetes and inflammation; Not using medications except for AR conventional drugs; No pregnancy or lactation
Exclusion criteria: developing illnesses which need particular cures or interfere with intervention such as increasing the disease activity or trauma; alcoholic; sensitivity to sesame
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total antioxidant capacity (TAC). Timepoint: Before the intervention and 6 weeks after intervention. Method of measurement: ELISA.
- Secondary Outcome Measures
Name Time Method TNF-alpha. Timepoint: Before the intervention and 6 weeks after intervention. Method of measurement: ELISA.;Interlukin 6. Timepoint: Before the intervention and 6 weeks after intervention. Method of measurement: ELISA.